Identity confirmed with an official business registry. How we verify
Eugia Pharma recently introduced Hydralazine Hydrochloride Injection to the Canadian healthcare market. It is a generic equivalent to APRESOLINE, a sterile solution formulated to treat hypertension. Each single-use vial contains 20 mg/ml of hydralazine hydrochloride and is engineered for intravenous administration, with a latex-free stopper. The company also offers Sulfamethoxazole and Trimethoprim Injection, a generic equivalent to SEPTRA, available in Canada.
Description based on the company's website.
Official data
- Registry
- Corporations Canada (sociétés fédérales)
- Number
- 13470717
- Legal name
- EUGIA PHARMA INC.
- Verified on
Contains information licensed under the Open Government Licence – Canada.
Products manufactured
Product illustrations, until the company adds its own photos.
The factor-by-factor breakdown, the comparison of your suppliers and alerts are reserved for buyer accounts. See the details and compare
Request a quote
Contact via Tritonis: the Tritonis team forwards your request to Eugia Pharma and follows it up until it gets a reply; we will write to you as soon as there is news. Indicative forwarding time: 5 business days.
Spotted an error on this listing?
Report it: we review every report, usually within two business days. No account is needed.
Recently viewed
